We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension.
- Authors
van de Kerkhof, P C M; Segaert, S; Lahfa, M; Luger, T A; Karolyi, Z; Kaszuba, A; Leigheb, G; Camacho, F M; Forsea, D; Zang, C; Boussuge, M P; Paolozzi, L; Wajdula, J
- Abstract
In previous studies, etanercept 25 mg twice weekly (BIW) or 50 mg BIW significantly reduced disease severity in patients with plaque psoriasis and demonstrated a favourable safety profile.
- Publication
The British journal of dermatology, 2008, Vol 159, Issue 5, p1177
- ISSN
1365-2133
- Publication type
Journal Article
- DOI
10.1111/j.1365-2133.2008.08771.x